Drugs / Recombinant Norovirus Hexavalent Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05805618 | Jul → Nov 2024 | gastroenteritis | Syneos Health | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Recombinant Norovirus Hexavalent Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05805618 ↗ |
| Route | Intramuscular | “intramuscular injections of study vaccines” NCT05805618 ↗ |